#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16394	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2272	718.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1574	1574	C	979	C	901	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3462	882.1	0	.	n	.	0	T695C	SNP	695	695	T	965	965	C	929	C	855	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3462	882.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1607	1607	A	987	A	921	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3462	882.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2241	2241	C	968	C	906	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3462	882.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2867	2867	T	948	T	892	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30676	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3462	882.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2315	2315	A	997	A	926	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	V36A	NONSYN	106	108	GTG	496	498	GCG	244;245;244	G,A;C;G	220,1;223;223	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	538	540	CGG	243;248;250	C;G;G	222;227;230	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	S68L	NONSYN	202	204	TCG	592	594	TTG	235;235;234	T;T,C;G	213;221,1;222	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	A90V	NONSYN	268	270	GCG	658	660	GTT	217;216;214	G;T;T	203;201;201	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	I105V	NONSYN	313	315	ATT	703	705	GTT	190;185;182	G;T;T	182;172;172	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	N125T	NONSYN	373	375	AAT	763	765	ACC	209;209;206	A;C,T;C	190;190,1;190	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	R135C	NONSYN	403	405	CGT	793	795	TGT	227;226;228	T;G;T	202;208;210	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	K151E	NONSYN	451	453	AAA	841	843	GAA	201;199;201	G;A;A	189;187;189	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	T152N	NONSYN	454	456	ACC	844	846	AAC	200;198;194	A;A;C	188;187;184	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	A172T	NONSYN	514	516	GCG	904	906	ACA	160;161;160	A;C;A	152;154;151	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	A175E	NONSYN	523	525	GCG	913	915	GAA	152;153;154	G;A;A	146;148;148	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	E176T	NONSYN	526	528	GAA	916	918	ACC	156;159;157	A;C;C	148;153;152	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	I178V	NONSYN	532	534	ATC	922	924	GTC	157;158;155	G;T;C	149;149;147	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	I188T	NONSYN	562	564	ATA	952	954	ACG	161;158;159	A;C;G,T	150;146;146,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	P200N	NONSYN	598	600	CCC	988	990	AAC	171;170;169	A;A;C	161;163;162	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1048	1050	TTG	182;183;184	T;T;G	170;172;173	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1105	1107	ACC	176;173;175	A;C;C	160;159;160	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1108	1110	GAC	174;177;179	G;A;C,A	156;160;159,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1117	1119	GCG	183;183;181	G;C,A;G	164;142,1;158	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1153	1155	GCT	170;171;170	G;C;T	158;160;156	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	2042	folP	858	858	91.61	folP.l15.c30.ctg.1	1563	130.0	1	SNP	p	R230S	1	.	.	688	690	AGC	1078	1080	AGC	195;192;191	A;G;C	185;180;180	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6480	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3389	190.3	1	SNP	p	S91F	0	.	.	271	273	TCC	629	631	TCC	214;215;217	T;C,T;C	202;204,1;205	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6480	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3389	190.3	1	SNP	p	D95G	0	.	.	283	285	GAC	641	643	GAC	218;216;217	G;A;C	205;204;205	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6480	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3389	190.3	1	SNP	p	D95N	0	.	.	283	285	GAC	641	643	GAC	218;216;217	G;A;C	205;204;205	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1964	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1267	153.7	1	SNP	p	G45D	1	.	.	133	135	GAC	501	503	GAC	221;220;220	G;A;C	206;205;206	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1032	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1032	99.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6018	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2894	206.7	1	SNP	p	D86N	0	.	.	256	258	GAC	472	474	GAC	237;239;238	G;A;C	220;221;223	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6018	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2894	206.7	1	SNP	p	S87R	0	.	.	259	261	AGT	475	477	AGT	236;238;238	A,C;G;T	219,1;223;217	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6018	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2894	206.7	1	SNP	p	S87I	0	.	.	259	261	AGT	475	477	AGT	236;238;238	A,C;G;T	219,1;223;217	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6018	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2894	206.7	1	SNP	p	S87W	0	.	.	259	261	AGT	475	477	AGT	236;238;238	A,C;G;T	219,1;223;217	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	6018	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2894	206.7	1	SNP	p	S88P	0	.	.	262	264	TCC	478	480	TCC	235;232;232	T;C,A;C	215;216,1;215	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5032	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2564	195.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1528	1530	GGC	227;225;223	G;G;C,T	212;206;205,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1265	1267	GCA	263;263;268	G;C;A	246;241;249	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1268	1270	ATC	267;270;269	A;T,C;C	249;250,1;250	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1280	1282	GTG	274;276;273	G;T;G	251;251;251	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1280	1282	GTG	274;276;273	G;T;G	251;251;251	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1784	1786	ACC	243;241;241	A;C;C	216;217;218	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1838	1840	GCG	215;217;216	G;C;G	196;183;193	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1838	1840	GCG	215;217;216	G;C;G	196;183;193	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1961	1963	GGC	188;183;182	G;G;C	175;171;171	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1970	1972	GGC	170;169;169	G;G;C	159;155;156	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4500	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2394	187.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1988	1990	CCG	149;149;149	C,G;C;G	109,3;109;107	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6562	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3070	212.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3010	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1847	162.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	510	510	C	180	C	167	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	G38E	NONSYN	112	114	GGA	388	390	GAA	275;276;276	G;A;A	249;253;253	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	S46G	NONSYN	136	138	AGC	412	414	GGC	256;255;253	G;G;C	237;236;234	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	418	420	GGA	254;256;256	G;G;A	237;237;236	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	535	537	GCT	248;250;249	G;C;T	225;228;227	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	541	543	AGC	246;244;244	A;G;C	226;223;221	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	633	634	CG	210;208	C;G	196;194	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	636	638	CAG	203;203;202	C;A;G	187;189;192	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	640	642	AAA	210;214;214	A;A;A	195;200;200	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	703	705	GAA	231;235;236	G;A;A	222;227;227	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	727	729	GCA	251;254;255	G;C;A	236;238;239	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	A215T	NONSYN	643	645	GCT	919	921	ACT	225;223;226	A,C;C;T	212,1;213;216	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	I218M	NONSYN	652	654	ATA	928	930	ATG	212;210;210	A;T;G	200;199;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1042	1044	GCA	268;268;271	G;C;A	253;253;255	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1045	1047	ACG	266;262;266	A;C,A;G	249;246,1;250	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	S258R	NONSYN	772	774	AGT	1048	1050	AGG	266;265;266	A;G;G	249;251;252	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1051	1053	GTT	265;264;264	G;T,G;T	252;247,1;250	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1111	1113	GTA	274;270;271	G;T;A	247;240;239	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1150	1152	ACT	273;272;272	A;C;T	241;244;244	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1156	1158	GAT	277;275;273	G,T;A;T	244,1;246;244	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1168	1170	CAC	278;278;279	C;A;C	253;255;256	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	1	SNP	p	G120K	1	.	.	358	360	AAG	633	635	CGG	210;208;205	C;G;G	196;194;190	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	1	SNP	p	D121N	0	.	.	361	363	GAC	636	639	CGC	203;202;207	C;G;C	187;192;193	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2998	porB1b	1047	1047	97.14	porB1b.l15.c17.ctg.1	1468	203.6	1	SNP	p	A121D	1	.	.	361	363	GAC	636	639	CGC	203;202;207	C;G;C	187;192;193	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11590	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4787	241.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1972	1974	CAT	241;242;243	C;A;T	226;230;231	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1306	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1089	119.4	1	SNP	p	V57M	1	.	.	169	171	ATG	535	537	ATG	279;284;288	A;T;G,C	267;270;272,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
